What are the implications in individuals with unilateral vestibular schwannoma and other neurogenic tumors?
JOURNAL OF NEUROSURGERY (2008)
期刊
JOURNAL OF NEUROSURGERY
卷 108, 期 1, 页码 92-96出版社
AMER ASSOC NEUROLOGICAL SURGEONS
关键词
作者
我是这篇论文的作者
推荐
Longitudinal Performance of Cochlear Implants in Neurofibromatosis Type 2
Stefanie Seo, Sarek Shen, Andy S. Ding, Francis X. Creighton
LARYNGOSCOPE (2023)
Vestibular schwannoma associated with neurofibromatosis type 2: Clinical course following stereotactic radiosurgery
Junhyung Kim, Yukyeng Byeon, Sang Woo Song, Young Hyun Cho, Chang-Ki Hong, Seok Ho Hong, Jeong Hoon Kim, Do Heui Lee, Ji Eun Park, Ho Sung Kim, Young-Hoon Kim
FRONTIERS IN ONCOLOGY (2022)
Establishment of nomograms for the prediction of useful hearing loss in patients with neurofibromatosis type 2
Shi-Wei Li, Jing Zhang, Han-Lu Tang, Peng Li, Bo Wang, Fu Zhao, Pi-Nan Liu
JOURNAL OF NEURO-ONCOLOGY (2021)
Stereotactic radiosurgery for vestibular schwannomas in neurofibromatosis type 2 patients: a systematic review and meta-analysis
Umberto Tosi, Omri Maayan, Anjile An, Miguel E. Tusa Lavieri, Sergio W. Guadix, Antonio P. DeRosa, Paul J. Christos, Susan Pannullo, Philip E. Stieg, Andrew Brandmaier, Jonathan P. S. Knisely, Rohan Ramakrishna
JOURNAL OF NEURO-ONCOLOGY (2022)
Neurofibromatosis Type-2 presenting with vision impairment
Sultan Abdulwadoud Alshoabi
PAKISTAN JOURNAL OF MEDICAL SCIENCES (2023)
Disease course of neurofibromatosis type 2: a 30-year follow-up study of 353 patients seen at a single institution
Claire Forde, Andrew T. King, Scott A. Rutherford, Charlotte Hammerbeck-Ward, Simon K. Lloyd, Simon R. Freeman, Omar N. Pathmanaban, Emma Stapleton, Owen M. Thomas, Roger D. Laitt, Stavros Stivaros, John-Paul Kilday, Grace Vassallo, Catherine McBain, Simon Kerrigan, Miriam J. Smith, Martin G. McCabe, Elaine F. Harkness, D. Gareth Evans
NEURO-ONCOLOGY (2021)
Long-term clinical outcomes of stereotactic radiotherapy for bilateral vestibular schwannomas in neurofibromatosis type 2 patients
Putipun Puataweepong, Mantana Dhanacha, Rawee Ruangkanchanasetr, Keeratikarn Boonyawan, Ake Hansasuta, Kriangsak Saetia, Pornpan Yongvithisatid
JOURNAL OF NEURO-ONCOLOGY (2023)
The genetic landscape and possible therapeutics of neurofibromatosis type 2
Mohammad Amin Ghalavand, Alimohamad Asghari, Mohammad Farhadi, Farzad Taghizadeh-Hesary, Masoud Garshasbi, Masoumeh Falah
CANCER CELL INTERNATIONAL (2023)
Multiple Meningiomas as a Criterion for the Diagnosis of Neurofibromatosis Type 2 and Other Tumor Predisposition Syndromes
Cathal John Hannan, Charlotte Hammerbeck-Ward, Omar Nathan Pathmanaban, Miriam J. Smith, Scott A. A. Rutherford, Simon K. K. Lloyd, Simon Richard Mackenzie Freeman, Andrew J. Wallace, Andrew Thomas King, Dafydd Gareth Richard Evans
NEUROSURGERY (2022)
Phase II trial of icotinib in adult patients with neurofibromatosis type 2 and progressive vestibular schwannoma
Fu Zhao, Shi-wei Li, Shun Zhang, Peng Li, Chi Zhao, Xiao-bin Zhao, Chun -Hong Wang, Jing Zhang, Bo Wang, Pi-nan Liu
JOURNAL OF NEUROSURGERY (2023)
Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2
Shilpa Prabhakar, Roberta L. Beauchamp, Pike See Cheah, Akiko Yoshinaga, Edwina Abou Haidar, Sevda Lule, Gayathri Mani, Katia Maalouf, Anat Stemmer-Rachamimov, David H. Jung, Bradley Welling, Marco Giovannini, Scott R. Plotkin, Casey A. Maguire, Vijaya Ramesh, Xandra O. Breakefield
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2022)
Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma
Scott R. Plotkin, Jeffrey Allen, Girish Dhall, Jian L. Campian, D. Wade Clapp, Michael J. Fisher, Rakesh K. Jain, James Tonsgard, Nicole J. Ullrich, Coretta Thomas, Lloyd J. Edwards, Bruce Korf, Roger Packer, Matthias A. Karajannis, Jaishri O. Blakeley
NEURO-ONCOLOGY (2023)
Vestibular dysfunction in neurofibromatosis type 2-related schwannomatosis
Amsal S. Madhani, Susan King, Jennifer Zhu, Faisal Karmali, D. Bradley Welling, Wenli Cai, Justin T. Jordan, Richard F. Lewis
BRAIN COMMUNICATIONS (2023)
Rationale and Design of BeatNF2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Bevacizumab in Patients with Neurofibromatosis Type 2 Related Vestibular Schwannoma
Masazumi Fujii, Masao Kobayakawa, Kiyoshi Saito, Akihiro Inano, Akio Morita, Mitsuhiro Hasegawa, Akitake Mukasa, Takafumi Mitsuhara, Takeo Goto, Shigeru Yamaguchi, Takashi Tamiya, Hirofumi Nakatomi, Soichi Oya, Fumiaki Takahashi, Taku Sato, Mudathir Bakhit
CURRENT ONCOLOGY (2021)
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas
Evan C. Cumpston, Steven D. Rhodes, Charles W. Yates
CURRENT ONCOLOGY REPORTS (2023)
Differential involvement of germline pathogenic variants in breast cancer genes between DCIS and low-grade invasive cancers
D. Gareth Evans, Siva Sithambaram, Elke Maria van Veen, George J. Burghel, Helene Schlecht, Elaine F. Harkness, Helen Byers, Jamie M. Ellingford, Ashu Gandhi, Sacha J. Howell, Anthony Howell, Claire Forde, Fiona Lalloo, William G. Newman, Miriam Jane Smith, Emma Roisin Woodward
JOURNAL OF MEDICAL GENETICS (2023)
RE: Heterozygous BRCA1/BRCA2 and mismatch repair gene pathogenic variants in children and adolescents with cancer
D. Gareth Evans, Emma R. Woodward
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)
Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes
Jose Garcia-Pelaez, Rita Barbosa-Matos, Silvana Lobo, Alexandre Dias, Luzia Garrido, Sergio Castedo, Sonia Sousa, Hugo Pinheiro, Liliana Sousa, Rita Monteiro, Joaquin J. Maqueda, Susana Fernandes, Fatima Carneiro, Nadia Pinto, Carolina Lemos, Carla Pinto, Manuel R. Teixeira, Stefan Aretz, Svetlana Bajalica-Lagercrantz, Judith Balmana, Ana Blatnik, Patrick R. Benusiglio, Maud Blanluet, Vincent Bours, Hilde Brems, Joan Brunet, Daniele Calistri, Gabriel Capella, Sergio Carrera, Chrystelle Colas, Karin Dahan, Robin de Putter, Camille Desseignes, Elena Dominguez-Garrido, Conceicao Egas, D. Gareth Evans, Damien Feret, Eleanor Fewings, Rebecca C. Fitzgerald, Florence Coulet, Maria Garcia-Barcina, Maurizio Genuardi, Lisa Golmard, Karl Hackmann, Helen Hanson, Elke Holinski-Feder, Robert Huneburg, Mateja Krajc, Kristina Lagerstedt-Robinson, Conxi Lazaro, Marjolijn J. L. Ligtenberg, Cristina Martinez-Bouzas, Sonia Merino, Genevieve Michils, Srdjan Novakovic, Ana Patino-Garcia, Guglielmina Nadia Ranzani, Evelin Schrock, Ines Silva, Catarina Silveira, Jose L. Soto, Isabel Spier, Verena Steinke-Lange, Gianluca Tedaldi, Maria-Isabel Tejada, Emma R. Woodward, Marc Tischkowitz, Nicoline Hoogerbrugge, Carla Oliveira
LANCET ONCOLOGY (2023)
ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1
Charlotte Carton, D. Gareth Evans, Ignacio Blanco, Reinhard E. Friedrich, Rosalie E. Ferner, Said Farschtschi, Hector Salvador, Amedeo A. Azizi, Victor Mautner, Claas Roehl, Sirkku Peltonen, Stavros Stivaros, Eric Legius, Rianne Oostenbrink
ECLINICALMEDICINE (2023)
Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations
Denise R. Nebgen, Susan M. Domchek, Joanne Kotsopoulos, Joanne A. de Hullu, Emma J. Crosbie, Vincent Singh Paramanandam, Monique Brood van Zanten, Barbara M. Norquist, Theresa Guise, Serge Rozenberg, Allison W. Kurian, Holly J. Pederson, Nese Yuksel, Rachel Michaelson-Cohen, Sharon L. Bober, Agnaldo Lopes da Silva, Nora Johansen, F. Guidozzi, D. Gareth Evans, Usha Menon, Sheryl A. Kingsberg, C. Bethan Powell, Giovanni Grandi, Claudia Marchetti, Michelle Jacobson, Donal J. Brennan, Martha Hickey
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2023)
Randomised controlled trial of breast cancer and multiple disease prevention weight loss programmes vs written advice amongst women attending a breast cancer family history clinic
Michelle Harvie, David P. French, Mary Pegington, Cheryl Lombardelli, Suzy Krizak, Katharine Sellers, Emma Barrett, D. Gareth Evans, Ramsey Cutress, Andrea Wilding Rgn, Lee Graves, Anthony Howell
BRITISH JOURNAL OF CANCER (2023)
Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study
Robert D. Morgan, Andrew R. Clamp, Bethany M. Barnes, Kirsten Timms, Helene Schlecht, Laura Yarram-Smith, Yvonne Wallis, Mikel Valganon-Petrizan, Suzanne MacMahon, Rhian White, Sian Morgan, Sarah McKenna, Emma Hudson, Laura Tookman, Angela George, Ranjit Manchanda, Sudha S. Sundar, Shibani Nicum, James D. Brenton, Rebecca S. Kristeleit, Susana Banerjee, Iain A. McNeish, Jonathan A. Ledermann, Stephen S. Taylor, D. Gareth R. Evans, Gordon C. Jayson
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2023)
MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1
Nicola Flaum, Emma J. Crosbie, Emma Roisin Woodward, Fiona Lalloo, Robert Morgan, Neil Ryan, D. Gareth Evans
JOURNAL OF MEDICAL GENETICS (2023)
TP53 c.455C>T p.(Pro152Leu) pathogenic variant is a lower risk allele with attenuated risks of breast cancer and sarcoma
D. Gareth Evans, Elaine F. Harkness, Emma R. Woodward
JOURNAL OF MEDICAL GENETICS (2023)
Automatic assessment of mammographic density using a deep transfer learning method
Steven Squires, Elaine Harkness, Dafydd Gareth Evans, Susan M. Astley
JOURNAL OF MEDICAL IMAGING (2023)
The effect of variable labels on deep learning models trained to predict breast density
Steven Squires, Elaine F. Harkness, D. Gareth Evans, Susan M. Astley
BIOMEDICAL PHYSICS & ENGINEERING EXPRESS (2023)
How do women at increased risk of breast cancer make sense of their risk? An interpretative phenomenological analysis
Victoria G. Woof, Lorna McWilliams, Anthony Howell, D. Gareth Evans, David P. French
BRITISH JOURNAL OF HEALTH PSYCHOLOGY (2023)
The comparable tumour microenvironment in sporadic and NF2-related schwannomatosis vestibular schwannoma
Grace E. Gregory, Adam Paul Jones, Michael J. Haley, Christopher Hoyle, Leo A. H. Zeef, I-Hsuan Lin, David J. Coope, Andrew T. King, D. Gareth Evans, Pawel Paszek, Kevin N. Couper, David Brough, Omar N. Pathmanaban
BRAIN COMMUNICATIONS (2023)
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium
Karin M. Kast, Esther L. John, John Hopper, Nadine Andrieu, Catherine Nogues, Emmanuelle Mouret-Fourme, Christine Lasset, Jean-Pierre Fricker, Pascaline Berthet, Veronique Mari, Lucie K. Salle, Marjanka Schmidt, Margreet G. E. M. Ausems, Encarnacion B. Gomez Garcia, Irma R. van de Beek, Marijke Wevers, D. Gareth Evans, Marc Tischkowitz, Fiona Lalloo, Jackie Cook, Louise Izatt, Vishakha Tripathi, Katie Snape, Hannah Musgrave, Saba Sharif, Jennie V. Murray, Sarah V. Colonna, Irene L. Andrulis, Mary B. Daly, Melissa C. Southey, Miguel de la Hoya, Ana Osorio, Lenka Foretova, Dita Berkova, Anne-Marie Gerdes, Edith Olah, Anna Jakubowska, Christian F. Singer, Yen Tan, Annelie Augustinsson, Johanna Rantala, Jacques Simard, Rita K. Schmutzler, Roger L. Milne, Kelly-Anne Phillips, Mary Beth Terry, David Goldgar, Flora E. van Leeuwen, Thea M. Mooij, Antonis C. Antoniou, Douglas F. Easton, Matti A. Rookus, Christoph Engel
BREAST CANCER RESEARCH (2023)
Estimating the Cost of 3 Risk Prediction Strategies for Potential Use in the United Kingdom National Breast Screening Program
Stuart J. Wright, Martin Eden, Helen Ruane, Helen Byers, D. Gareth Evans, Michelle Harvie, Sacha J. Howell, Anthony Howell, David French, Katherine Payne
MDM POLICY & PRACTICE (2023)